Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation.

Research output: Contribution to journalArticle

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Urology and Nephrology

Keywords

  • Research Support, Aged, Prostatic Neoplasms: pathology, Non-U.S. Gov't, Cell Transformation, Prostatic Neoplasms: metabolism, Chromogranins: metabolism, Cystatins: metabolism, Disease Progression, Humans, Ki-67 Antigen: metabolism, Male, Middle Aged, Neuroendocrine Tumors: metabolism, Neuroendocrine Tumors: pathology, Neoplastic
Original languageEnglish
Pages (from-to)189-196
JournalBJU International
Volume98
Issue number1
Publication statusPublished - 2006
Publication categoryResearch
Peer-reviewedYes

Bibliographic note

The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Division of Clinical Chemistry and Pharmacology (013250300), Pediatrics/Urology/Gynecology/Endocrinology (013240400), Clinical Chemistry, Malmö (013016000), Division of Urological Cancers (013243420)